Relaxo Footwears Intrinsic Value
RELAXO • Consumer Goods
Current Stock Price
₹280.13
Primary Intrinsic Value
₹167.50
Market Cap
₹700.3 Cr
+100.0%
Upside
Median Value
₹560.26
Value Range
₹84 - ₹700
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
RELAXO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹167.50 | ₹134.00 - ₹201.00 | -40.2% | EPS: ₹6.70, Sector P/E: 25x |
| Book Value Method | asset | ₹700.33 | ₹630.30 - ₹770.36 | +150.0% | Book Value/Share: ₹839.20, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹560.26 | ₹504.23 - ₹616.29 | +100.0% | Revenue/Share: ₹1075.60, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹560.26 | ₹504.23 - ₹616.29 | +100.0% | EBITDA: ₹405.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹700.33 | ₹560.26 - ₹840.40 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹84.04 | ₹75.64 - ₹92.44 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹120.67 | ₹108.60 - ₹132.74 | -56.9% | Revenue Growth: 0.1%, Adj P/E: 18.0x |
| ROE Based Valuation | profitability | ₹560.26 | ₹504.23 - ₹616.29 | +100.0% | ROE: 8.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹355.68 | ₹320.11 - ₹391.25 | +27.0% | EPS: ₹6.70, BVPS: ₹839.20 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
RELAXO Intrinsic Value Analysis
What is the intrinsic value of RELAXO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Relaxo Footwears (RELAXO) is ₹560.26 (median value). With the current market price of ₹280.13, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹84.04 to ₹700.33, indicating ₹84.04 - ₹700.33.
Is RELAXO undervalued or overvalued?
Based on our multi-method analysis, Relaxo Footwears (RELAXO) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.77 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.97x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Relaxo Footwears
Additional stock information and data for RELAXO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹406 Cr | ₹275 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹235 Cr | ₹186 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹400 Cr | ₹271 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹56 Cr | ₹56 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹513 Cr | ₹287 Cr | Positive Free Cash Flow | 8/10 |